In leukemia, this interaction causes chemotaxis of malignant cells to the bone marrow microenviroment where they are protected from chemotherapy.
Í sjúkdómsástandi eins og hvítblæði gefur þessi binding illkynja frumum vernd frá frumudrepandi krabbameinslyfjum.